Novo Holdings Treace Medical Concepts, Inc. Transaction History

Novo Holdings

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$23.91 - $27.81 $4.3 Million - $5.01 Million	-180,000 Reduced 33.33%	360,000 $9.21 Million
Q1 2023 May 15, 2023	SELL	$20.23 - $26.22 $1.97 Million - $2.55 Million	-97,317 Reduced 15.27%	540,000 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$20.54 - $24.67 $1.01 Million - $1.21 Million	49,009 Added 8.33%	637,317 $14.7 Million
Q2 2022 Aug 15, 2022	BUY	$12.93 - $20.29 $1.14 Million - $1.78 Million	87,887 Added 17.56%	588,308 $8.44 Million
Q4 2021 Feb 14, 2022	BUY	$15.48 - $26.52 $3.35 Million - $5.75 Million	216,652 Added 76.35%	500,421 $9.33 Million
Q3 2021 Nov 15, 2021	SELL	$24.15 - $30.5 $947,428 - $1.2 Million	-39,231 Reduced 12.15%	283,769 $7.63 Million
Q2 2021 Aug 16, 2021	BUY	$25.53 - $36.11 $8.25 Million - $11.7 Million	323,000 New	323,000 $10.1 Million

142

39.7M

352K

269K

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $524M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.